Overview
Hiroshi Semba practices in Kumamoto, Japan. Mr. Semba is rated as an Experienced expert by MediFind in the treatment of Febrile Neutropenia. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Agranulocytosis, and Interstitial Lung Disease.
His clinical research consists of co-authoring 19 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Febrile Neutropenia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Lung CancerMr. Semba isAdvanced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Experienced
- Acute Interstitial PneumoniaMr. Semba isExperienced. Learn about Acute Interstitial Pneumonia.
- AgranulocytosisMr. Semba isExperienced. Learn about Agranulocytosis.
- Febrile NeutropeniaMr. Semba isExperienced. Learn about Febrile Neutropenia.
- Interstitial Lung DiseaseMr. Semba isExperienced. Learn about Interstitial Lung Disease.
- Lung MetastasesMr. Semba isExperienced. Learn about Lung Metastases.